|
- 积分
- 1334
- 威望
- 1334
- 包包
- 4744
|
实在想做，可以看这里
o6 T: ~& Q( p9 a, L% Jhttp://clinicaltrials.gov/ct2/re ... +cord+AND+stem+cell
# K% u; p$ b4 W7 Q7 V8 _Found 57 studies with search of: spinal cord AND stem cell
: y2 _' d1 n* L( k2 N. B: }7 qHide studies that are not seeking new volunteers.& E% U5 I( F( t* }" ]
Hide studies with unknown recruitment status. Display Options Rank Status Study
; G9 A4 n: s% G$ b% J! E/ K1 Recruiting Autologous Bone Marrow Stem Cell Transplantation in Patients With Spinal Cord Injury Condition: Spinal Cord Injury
* g s+ W) m, d$ ?' Z! Y o5 l9 QIntervention: Procedure: Stem Cell Transplantation 8 ^( O: U7 |2 V4 D; z
: c8 S- f" p; x( Q5 j& v4 F* y2 Active, not recruiting Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis Condition: Amyotrophic Lateral Sclerosis
+ b$ K1 n/ V5 H( `Intervention: Procedure: surgical implantation
: ~) c2 w* I2 i3 ^ d5 }3 A ( o, S) o4 @& C: ~
3 Recruiting Autologous Stem Cells for Spinal Cord Injury (SCI) in Children Condition: Spinal Cord Injury
4 ^1 V: R* P9 h% E$ B+ o7 xIntervention: Biological: bone marrow progenitor cells (BMPC) autologous transplantation ' f+ @ P* z% e T' k ?
- Q, a- J/ @5 m4 Active, not recruiting Transfer of Bone Marrow Derived Stem Cells for the Treatment of Spinal Cord Injury Condition: Spinal Cord Injury
1 ^& q1 G! q. I* {( UIntervention: Biological: autologous mesenchymal stem cells
: y4 H) l5 j, Y3 b% S# X4 S
1 ~" k" Z6 @7 t( l1 V2 E" e0 F5 Recruiting Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Patients With Thoracic Spinal Cord Injury Conditions: Spinal Cord Injury Thoracic; Spinal Cord Injury
# w- v. w! i# f( qIntervention: Procedure: HuCNS-SC cells
9 D# ? o1 h( r) u4 P , o1 h$ c) i6 u: e8 |& u9 z
6 Completed Safety and Efficacy of Autologous Bone Marrow Stem Cells in Treating Spinal Cord Injury Condition: Spinal Cord Injuries . u( [* q8 v( ^; E. H+ s
Interventions: Procedure: laminectomy; Procedure: Intrathecal 7 V# j8 e7 r; K: D4 }! n
R3 L; c% E/ d6 }% p7 Completed Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors Conditions: Brain and Central Nervous System Tumors; Neuroblastoma; Sarcoma 2 a- s- e; a2 ]9 e$ e1 Y5 N
Interventions: Biological: filgrastim; Drug: carboplatin; Drug: cisplatin; Drug: cyclophosphamide; Drug: etoposide; Drug: thiotepa; Drug: vincristine sulfate; Procedure: conventional surgery; Procedure: peripheral blood stem cell transplantation * I% n0 z6 z1 ~8 C2 x
& X+ E" Y% O9 [( c6 z% S* h% m
8 Completed Autologous Adipose Derived MSCs Transplantation in Patient With Spinal Cord Injury. Condition: Spinal Cord Injury
2 t' s: Q+ ?+ t3 B4 eIntervention: Other: Autologous Adipose Derived Mesenchymal Stem Cells & l& B: U, E- g; U6 a& ~; I
& b$ ]' n$ v- {1 }' }9 Recruiting Bone Graft Materials Observational Registry Conditions: Degenerative Disc Disease; Herniated Disc; Spinal Stenosis; Spondylolithesis; Spinal Deformity; Cervical Myelopathy; Failed Back Surgery Syndrome; Spinal Cord Neoplasms
% D/ q7 F7 E$ a- ^Intervention: Device: Bone growth substitute, autograft or allograft 8 H( @( T3 m* }8 _
3 @% [0 ]+ [$ m3 x+ E9 p' }. _
10 Recruiting Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Autoimmune Neurologic Disease That Did Not Respond to Previous Therapy Condition: Autoimmune Disorder 0 O( J- T: e: g/ N1 C
Interventions: Biological: anti-thymocyte globulin; Drug: carmustine; Drug: cytarabine; Drug: etoposide; Drug: melphalan; Drug: prednisone; Procedure: autologous hematopoietic stem cell transplantation; Procedure: peripheral blood stem cell transplantation; Procedure: syngeneic bone marrow transplantation; Other: laboratory biomarker analysis
6 X b# o2 w2 P 0 }& L+ g' F9 N3 a. r9 ?% X$ ?" @. f
11 Active, not recruiting Hematopoietic Stem Cell Therapy for Patients With Multiple Sclerosis Condition: Multiple Sclerosis
j1 N$ F0 C. E, t" w# V9 B2 ?$ G0 ~Intervention: Procedure: hematopoietic stem cell transplantation 8 q5 G7 _1 z' K: J+ L
4 d" w! K: |, m0 V12 Recruiting Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica Condition: Neuromyelitis Optica (NMO)
8 {8 w# W* B6 j( b: H% [Intervention: Procedure: AHSCT 5 M2 }2 k' S. j& j# U* |
1 j C) a/ r. a( ~: C Y" q13 Active, not recruiting High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study Condition: Multiple Sclerosis
5 X8 Y6 Y7 f; V9 w# UInterventions: Drug: Granulocyte-colony stimulating factor (G-CSF) and prednisone; Drug: Carmustine, etoposide, cytarabine, and melphalan (BEAM); Procedure: Autologous hematopoietic stem cell transplant 3 B4 E9 V N- V* O. M& V3 |
0 ?; x, u# W4 Q5 n
14 Completed Cell Transplant in Spinal Cord Injury Patients Condition: Chronic Spinal Cord Injury
& T: |' r- T4 P6 hInterventions: Procedure: Autologous bone marrow transplant; Procedure: Physical therapy
; [; _$ O3 p9 i
+ t, J" I8 d+ q/ b/ n# E15 Active, not recruiting Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic
" R7 n" u: R! M5 y; K; L% XInterventions: Drug: fludarabine phosphate; Drug: cyclophosphamide; Biological: Rituxan (rituximab); Biological: filgrastim; Drug: methylprednisolone; Other: immunologic technique; Other: laboratory biomarker analysis; Procedure: autologous hematopoietic stem cell transplantation 3 N9 A; c' T- J9 M+ b0 g- x
6 _& Y+ h: u( S8 |
16 Unknown † Mesenchymal Stem Cells for the Treatment of MS Condition: Multiple Sclerosis 6 _$ L& D" r. G
Intervention: Biological: injection of autologous stem cells 8 f& X: r/ }8 _. g5 s. o
3 t. T/ W$ a5 @" G17 Recruiting Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma Condition: Lymphoma
4 O0 E/ g$ K/ J# Q) pInterventions: Drug: carmustine; Drug: cyclophosphamide; Drug: etoposide; Procedure: peripheral blood stem cell transplantation; Radiation: radiation therapy; Biological: G-CSF
3 r2 N% J/ U4 r/ v b6 g$ U $ w9 _+ u% f% D% \$ B) x2 y
18 Recruiting Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma Condition: Sarcoma
4 o/ n, E! X% G; p+ Z$ ?Interventions: Biological: dactinomycin; Drug: busulfan; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: ifosfamide; Drug: melphalan; Drug: vincristine sulfate; Procedure: autologous hematopoietic stem cell transplantation; Procedure: conventional surgery; Radiation: radiation therapy 7 c+ a/ v9 n+ ?1 b
: y8 T( E* ?8 K: E; X' P# X: A19 Recruiting Clinical Trial on The Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis (Extension CMN/ELA) Condition: Amyotrophic Lateral Sclerosis
5 M/ K! \( i& h; n5 ~5 a+ UInterventions: Procedure: Laminectomy and bone marrow stem cells transplantation; Procedure: Intrathecal infusion of autologous bone marrow stem cells; Procedure: Intrathecal infusion of placebo (saline solution).
% j; Z! O3 p" m K# \. M
9 N9 ?) P6 U/ c) j20 Active, not recruiting Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma Condition: Neuroblastoma
$ a4 {$ w* ?2 v" [; J9 NInterventions: Drug: Cisplatin and Etoposide; Drug: Adriamycin and Cyclophosphamide / W0 Z) E; C3 m w
3 T3 U- u9 w) l8 Y. pFound 57 studies with search of: spinal cord AND stem cell
: E) ~% R6 _2 _- x& g; |9 `1 i( iHide studies that are not seeking new volunteers.
2 H5 y1 y2 C( ^& a3 Z+ xHide studies with unknown recruitment status. Display Options Rank Status Study
% ~ Y! B3 L% Q6 r, D# U, {21 Completed Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis Condition: Amyotrophic Lateral Sclerosis / r" ^: Q# c S2 q( t$ S
Interventions: Procedure: Laminectomy and bone marrow stem cells transplantation; Procedure: Autologous bone marrow cells collection
) t2 K1 m0 j% f4 W- D# {
/ I3 C& i8 Q) ]2 R( l" o22 Active, not recruiting Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS) Condition: Amyotrophic Lateral Sclerosis
' A$ Y& \* T6 YIntervention: Biological: autologous mesenchymal stem cells
6 M: \4 t" |* H( l
$ r# v% i" A! P23 Active, not recruiting Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis Condition: Amyotrophic Lateral Sclerosis
# h. L$ ~7 g( P; }# LIntervention: Biological: autologous bone marrow-derived stem cells K6 q/ z6 h2 d# k, m" K5 @$ Q- V
( L& A" P! r9 r# W, e$ @24 Unknown † Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical Response Condition: Amyotrophic Lateral Sclerosis $ p! ], R2 x7 l6 w: J: F* F
Intervention: Drug: Cistanche Total Glycosides 2 S, G( m- v7 O' H" E" m
' \( U3 Q# K6 P0 t8 s9 c* `, b
25 Completed G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response Condition: Amyotrophic Lateral Sclerosis : i* Q9 j! X4 j8 H
Interventions: Drug: Granulocyte Colony Stimulating Factor; Drug: NS 0 ]+ p: t( i5 k5 ~; a) F
8 S2 t, y% w6 s' L' {& Q( E26 Active, not recruiting Derivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic Cells Condition: Amyotrophic Lateral Sclerosis + l& t1 q/ r' Y: q% l* c1 S$ m
Intervention:
# e2 s( U. Y4 T" C
, w! {& X7 n# C- c, T p+ A" y27 Not yet recruiting Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients. Condition: Amyotrophic Lateral Sclerosis # S# o+ h! W$ B7 f% _
Interventions: Biological: MSC-NTF cells transplantation (i.m.); Biological: MSC-NTF cells transplantation (i.t.) / \$ J: C8 H1 d4 ~# \2 E8 p3 m
F) n8 q- m3 E# j28 Active, not recruiting Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS) Condition: Amyotrophic Lateral Sclerosis
, ^9 l7 b/ t1 b+ _' y; qIntervention: Drug: SB-509 ( ?& O6 v9 i# W: [
+ V R9 k' u6 T# h/ V; t
29 Active, not recruiting Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Conditions: Brain and Central Nervous System Tumors; Extra-adrenal Paraganglioma 9 `1 b* D/ l ?) c4 _3 C' F" i( \
Interventions: Drug: temozolomide; Drug: vorinostat; Genetic: DNA methylation analysis; Genetic: western blotting; Other: laboratory biomarker analysis; Other: pharmacological study . ?; m3 }. a% Z, n
' ?8 ] u% b+ }7 }30 Active, not recruiting Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors Conditions: Brain and Central Nervous System Tumors; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific 4 M1 _, b! w- |
Interventions: Drug: carboplatin; Drug: tamoxifen citrate; Drug: topotecan hydrochloride; Other: pharmacological study
' o- @- g/ Y6 Y2 |- G9 f ( R. T, j7 m7 \! {* T# v
31 Recruiting Efficacy and Safety of Umbilical Cord Blood Injection for Critical Limb Ischemia Condition: Critical Limb Ischemia
4 t1 ^& {8 @1 V9 l) |+ H- _: u: jIntervention: Biological: Cord blood stem cell injection * u8 ~3 h, L Z! ^6 C+ P
( t) h4 s# r; y |
|
发表于 2011-5-21 11:11
。。。。可否提供中文的信息，谢谢。/ G/ A# [0 U6 _% @' L9 o! H! I
我看看先，看看有没有可行性的方案。